San Francisco, CA, United States of America

Samuel Levy

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Clearnote Health, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Levy. Retrieved from https://idiyas.com/inventor/samuel-levy-t2mnwqvz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Samuel Levy - Innovator in Biological Analysis

Introduction

Samuel Levy is an inventor based in San Francisco, CA (US). He currently works at Clearnote Health, Inc. Although he has not yet been granted any patents, his contributions to the field of biological analysis are noteworthy. Samuel collaborates with talented coworkers, including Chin-Jen Ku and Francois Collin.

Latest Patent Applications

Samuel Levy's latest patent applications include innovative methods for analyzing biological samples. One of his applications, titled "Simultaneous, Sequencing-Based Analysis of Proteins, Nucleosomes, and Cell-Free Nucleic Acids from a Single Biological Sample," provides a streamlined workflow for obtaining multiple types of information from a biological sample. This method allows for the determination of specific plasma proteins, histone modifications, and epigenetic information from a single blood sample. Another significant application is "Pancreatic Ductal Adenocarcinoma Evaluation Using Cell-Free DNA Hydroxymethylation Profile," which focuses on identifying patients at risk for pancreatic ductal adenocarcinoma (PDAC) and improving patient monitoring and treatment evaluation.

Conclusion

Samuel Levy is making strides in the field of biological analysis through his innovative patent applications. His work has the potential to significantly impact patient diagnosis and treatment in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…